Showing 1 - 7 results of 7 for search 'David A. Brown', query time: 0.01s
Refine Results
-
1
-
2
A systematic review of the neuroprotective role and biomarker potential of GDF15 in neurodegeneration by Finula I. Isik, Shannon Thomson, John F. Cueto, Jessica Spathos, Samuel N. Breit, Vicky W. W. Tsai, David A. Brown, David A. Brown, David A. Brown, Caitlin A. Finney, Caitlin A. Finney
Published 2024-12-01Get full text
Article -
3
-
4
Effects of KCNQ2 gene truncation on M-type Kv7 potassium currents. by Jon Robbins, Gayle M Passmore, Fe C Abogadie, Joanne M Reilly, David A Brown
Published 2013-01-01Get full text
Article -
5
44. Describing “Operative Burden” In Long-term Surgical Protocols for Cleft Lip/Palate: A Proof-of-concept Data-visualization Tool by Elaine Lin, BS, Victoria N. Yi, BA, Kristina Dunworth, MD, Ashit Patel, MB ChB, David A. Brown, MD, PhD, Alexander C. Allori, MD, MPH
Published 2025-05-01Get full text
Article -
6
-
7
Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial by Amel Karaa, Enrico Bertini, Valerio Carelli, Bruce Cohen, Gregory M. Ennes, Marni J. Falk, Amy Goldstein, Gráinne Gorman, Richard Haas, Michio Hirano, Thomas Klopstock, Mary Kay Koenig, Cornelia Kornblum, Costanza Lamperti, Anna Lehman, Nicola Longo, Maria Judit Molnar, Sumit Parikh, Han Phan, Robert D. S. Pitceathly, Russekk Saneto, Fernando Scaglia, Serenella Servidei, Mark Tarnopolsky, Antonio Toscano, Johan L. K. Van Hove, John Vissing, Jerry Vockley, Jeffrey S. Finman, Anthony Abbruscato, David A. Brown, Alana Sullivan, James A. Shiffer, Michelango Mancuso, on behalf of the MMPOWER-3 Trial Investigators
Published 2024-11-01Get full text
Article